Why Shares of Johnson & Johnson Are Down 2% Today
Shares of Johnson & Johnson (NYSE: JNJ) are down more than 2% as of 3:25 p.m. EDT Thursday as potential regulation for prescription drug prices becomes clearer.
Image source: Getty Images.
Today, the U.S. Department of Health and Human Services released the Biden administration's plan to drive down costs. It supports allowing the federal government to negotiate drug prices in its Medicare program. That's the federal insurance program for people aged 65 and older. Medicare also includes younger people with disabilities.
Source Fool.com